# Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.

> **NCT05477394** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 90 (actual)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05477394
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-01-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05477394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05477394, "Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05477394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*